
IndraLab
Statements
sparser
"Other downstream targets of AMPK include TSC2, which inhibits mammalian target of rapamycin complex 1 (mTORC1) and protein synthesis; xref HMG-CoA reductase, which leads to the inhibition of cholesterol synthesis; xref peroxisome proliferator-activated receptor-gamma coactivator (PPARα) 1α, which stimulates mitochondrial biogenesis, xref , xref and many others."
reach
"Since hamartin and tuberin negatively regulate mTOR activity, which in turn phosphorylates and thereby activates important translation factors such as p70 S6 kinase 1 (S6K1) and eukaryote initiation factor 4E binding protein (eIF4E-BP), a major role of the TSC-mTOR signaling pathway has been suggested for tumorigenesis, and both genes were initially recognized as tumor suppressors [XREF_BIBR]."
reach
"Signaling through mTOR is also controlled by upstream members of the pathway such as the Ras homolog enriched in brain (Rheb), a GTPase that activates mTOR, and tuberin (also known as TSC2), a GTPase activating protein, which, with its binding partner hamartin (also known as TSC1), acts to repress mTOR."
reach
"Akt can directly phosphorylate and activate mTOR, as well as indirectly activating it by phosphorylating and inactivate tuberous sclerosis complex 2 (TSC2), also called tuberin, which normally inhibits mTOR through the GTP binding protein Ras homolog enriched in brain (Rheb) [XREF_BIBR]."
reach
"In normal and adult kidney, PC1 functions by inducing the formation of PC1, tuberin, and mTOR complex thereby inhibiting mTOR activity XREF_BIBR, yet in human ADPKD patients and mouse models, null of PC1 leads to the inability to assemble this inhibitory complex thereby causing mTOR pathway inappropriately activated XREF_BIBR, XREF_BIBR."
reach
"We can not exclude that Tsc2 might have additional unidentified functions that compensate Tsc1-mutant phenotypes; however, since the loss of either Tsc1 or Tsc2 abolishes the Rheb-GTPase-activating activity, resulting in constitutively activated mTOR, it is unlikely that Tsc2 alone can suppress mTOR activation in the absence of Tsc1."
reach
"AMPK promotes autophagy by at least the following ways : phosphorylating the tuberous sclerosis (TSC) complex proteins TSC1 and TSC2, which in turn downregulate mTOR activity and induce autophagy 59, phosphorylating FOXO3, phosphorylating ULK1, and dissociating Beclin1 and Bcl-2 by stimulating JNK1-Bcl-2 signaling XREF_BIBR - XREF_BIBR."
reach
"Once activated, AMPK can phosphorylate several downstream targets: the phosphorylation of acetyl coenzyme A (CoA) carboxylase inhibits fatty acid synthesis; the phosphorylation of hamartin (also known as TSC1) and TSC2 inhibits protein synthesis and anabolic metabolism (via effects on mTOR); and the phosphorylation of p53 promotes mitochondrial respiration and causes cell cycle arrest and apoptosis."
reach
"TSC1 and TSC2 negatively regulate the activity of the mammalian target of rapamycin complex 1 (mTORC1), and deletion of Tsc1 or Tsc2 from mouse oocytes in primordial and further developed follicles has been shown to cause overactivation of the entire ovarian pool and subsequent POF in early adulthood [69,70]."
reach
"Thomas Weichhart from the Medical University of Vienna presented a mouse model in which deletion of the tuberous sclerosis 2 (TSC2) gene in myeloid cells induces constitutive mTOR activation, followed by spontaneous multiorgan granuloma formation that appears to be more chronic than many prior murine granuloma models."
reach
"TSC2 is an essential component in the formation of a functional heterodimer to suppress MTORC1 activity, and loss of TSC2 leads to the constitutive MTOR activation and impaired autophagy.32 The effects of MBCD disruption on the autophagic flux were similar in both Tsc2C/C and tsc2!"
reach
"The PTEN and TSC2 tumor suppressors function to antagonize mTOR (mammalian target of rapamycin) activation by Akt; hence, compound heterozygous inactivation of Pten and Tsc2 in the mouse may in principle exacerbate the tumor phenotypes observed in the single mutants in a reciprocal manner."
reach
"Given that TSC2 inhibits MTOR at the lysosomes in response to nutrient shortage [43], one can hypothesize that increased TSC2 leads to overactivation of autophagy potentially affecting neuronal development in EZH2-deficient cells.Methylation of H3K9 is another repressive histone mark associated with silenced autophagy-related gene expression [44–46]."
sparser
"A great deal of ground breaking work has determined that the Tuberin and Hamartin Complex function as a negative regulator of protein synthesis and cell cycle progression through G1/S. This is largely attributed to the GTPase activity of Tuberin that indirectly inhibits the mammalian target of rapamycin (mTOR)."
reach
"Interestingly, while we previously showed activation of AMPKalpha and downstream tumor suppressor TSC2 which act to inhibit mTOR in both U251 and U87 parental cells [XREF_BIBR], U87TMZ appears to have lost the ability to act through this pathway which suggests direct inhibition of the Akt and mTOR axis."
reach
"The tumor suppressor tuberin, the TSC2 gene product, negatively regulates the mammalian target of rapamycin (mTOR) pathway, which is a key regulator of cell growth and proliferation and increasing evidence suggests that its deregulation is associated with human chronic diseases, including cancer [XREF_BIBR]."
reach
"The activation of AMPK by LKB1 leads to phosphorylation of tuberous sclerosis complex 2 (TSC-2), which in turn inhibits the mTOR protein (mammalian target of rapamycin), a key protein which regulates processes of cell growth and angiogenesis, and promotes cell division and protein synthesis."
reach
"Activation of AMPK leads to suppression of mammalian target of rapamycin (mTOR) signaling, and the molecular mechanisms involve phosphorylation of tuberous sclerosis complex protein TSC2 at Thr 1227 and Ser 1345 that increases the activity of the TSC1 and TSC2 complex to inhibit mTOR [XREF_BIBR, XREF_BIBR]."
reach
"To investigate whether the suppressed AKT and mTOR pathway contributes to the reversibility of contact inhibition, they designed shRNA that silenced the expression of TSC2, an AKT substrate that inhibits mTOR activity by suppressing the mTOR activating small GTP binding protein Rheb."
eidos
"54 In addition , phosphorylated AKT ( p-Akt ) can inhibit TSC2 and TSC to activate mTOR ,55 and mTOR can induce mRNA translation by phosphorylating S6K and then p70S6K to increase the adhesion of ribosomes to the endoplasmic reticulum and thereby inhibit both the formation of autophagic membranes and autophagy activity.56 ,57 The corresponding results from our study showed that LACTB might inhibit the level of PIK3R3 to reduce the levels of PI3K , p-AKT and mTOR and thereby promote autophagy ."
reach
"However, treatment was not restricted to mTOR-addicted tumors as this may have led to more favorable outcomes through screening for patients with either tissue or liquid biopsy-proven β-catenin mutated HCC or tumors with loss of tuberous sclerosis complex 2 (TSC2), which both lead to increased mTOR signaling.54 55 Thus, subsets of patients with mTOR-addicted tumors may benefit from mTOR inhibitors in neoadjuvant or adjuvant settings."
reach
"Activation of AMPK, a target of several glucose lowering agents used in diabetes treatment, including metformin and the thiazolidenediones, stimulates insulin action in peripheral tissues, acting to phosphorylate and stimulate the TSC1 : TSC2 complex, which subsequently inactivates mammalian target of rapamycin and regulatory associated protein of mTOR (mTOR and Raptor)."
sparser
"In a previous study, Chen et al. found that active TSC2 inhibits mTOR through RHEB by detecting differential phosphorylation of short TSC2 or long TSC2 splicing variants and its effect on mTOR signaling pathway, leading to continuous stimulation of carcinogenic autophagy in ESCC cells ( xref )."
sparser
"Metformin activates AMPK indirectly via a suppressor protein, liver kinase B1 (LKB1), and via the activation of tuberous sclerosis complex 2 (TSC-2) which inhibits the mammalian target of rapamycin (mTOR) protein, one of the key proteins in regulating cell division, protein synthesis, growth and angiogenic processes [ xref , xref ]."
reach
"Supporting an increased protein degradation relative to synthesis due to food deprivation, starved trout muscle contained high levels of the transcript for tuberous sclerosis component 2 (TSC2) which has been shown, in mammals, to inhibit mTOR a positive regulator of cell growth and proliferation [XREF_BIBR], and of the transcript encoding the translational repressor 4E-BP1, which presumably reinforces the inhibition of cap dependent translation resulting from inactivation of Akt and mTOR [XREF_BIBR]."
reach
"Our study demonstrates that IFNbeta dependent activation of STATs and p38 MAPK is not sufficient to fully inhibit proliferation of cells with TSC2 dysfunction and that TSC2 dependent inhibition of mTOR and S6K1 cooperates with IFNbeta in inhibiting human LAM and TSC2-null ELT3 cell proliferation."
reach
"HIF-1α is activated by the mechanistic target of rapamycin (mTOR) and, typically, in response to food intake, the body will indirectly activate mTOR due to chain signaling from Insulin Receptor Substrate (IRS) to Phosphoinositide 3-kinase (PI3K) and then Protein Kinase B (Akt), resulting in the inactivation of Tuberous Sclerosis Complex 2 (TSC2) (which is a suppressor of mTOR), and thus activation of HIF-1α and glucose uptake."
reach
"Loss or impaired function of either Tsc1 or Tsc2, which together act to negatively regulate mTOR signaling, leads to strong and sustained mTOR signaling activation 13.Notably, the Ras/Mek/Erk pathway is also highly activated in 50-100% of HCCs and correlated with a poor prognosis 14."
reach
"It has conventionally been believed that the effect of AMPK on cell growth is mediated through inhibition of mTOR via phosphorylation of the tuberous sclerosis complex (TSC2), a subunit of the larger TSC1 and TSC2 (hamartin and tuberin) complex that negatively regulates mTOR signaling."
sparser
"The tumor suppressor genes, such as PTEN, tuberous sclerosis complex 1 (TSC1), and tuberous sclerosis complex 2 (TSC2) can inhibit the upstream signal of mTOR and stimulate autophagy, while PI3K/Akt inhibits autophagy by activating mTOR signaling pathway. xref In this review, we focus on autophagy induced by resveratrol through the regulation of mTOR and p62 signaling pathway."
reach
"15 ATM is exported to the cytoplasm in response to high concentration of ROS and reactive nitrogen species (RNS) like nitric oxide (NO), and deactivates mTOR through a series of phosphorylation dependent activation processes involving liver kinase B1 (LKB1), AMPK and the tumor suppressor tuberous sclerosis 2 (TSC2)."
reach
"Other downstream targets of AMPK include TSC2, which inhibits mammalian target of rapamycin complex 1 (mTORC1) and protein synthesis; XREF_BIBR HMG-CoA reductase, which leads to the inhibition of cholesterol synthesis; XREF_BIBR peroxisome proliferator activated receptor-gamma coactivator (PPARalpha) 1alpha, which stimulates mitochondrial biogenesis, XREF_BIBR, XREF_BIBR and many others."
reach
"It is possible that they express negative mTOR regulators such as TSC2, which limits mTOR signalling in Drosophila intestinal stem cells but not progenitors, or that stem cells are more adept than progenitors at using low levels of nutrients for proliferation, perhaps because of their slower cycling."
reach
"In mouse oocytes, disruption of the negative mTOR regulators Tsc1 (Adhikari et al. 2010) and Tsc2 (Adhikari et al. 2009) led to overactivation of primordial follicles and subsequent infertility, though interestingly, mTOR itself may not be necessary for primordial follicle activation due to compensatory potential of the PI3K/Akt pathway."
reach
"Therefore, in both assays, the TSC2 I820del and L1511H variants were unable to inhibit mTOR, indicating that both these variants are pathogenic, while the TSC2 R1772C and T993M variants were just as active as wild-type TSC2 and are therefore not pathogenic amino acid substitutions."
reach
"Cheng Y et al. (80) found that knockdown of the TSC1/TSC2 gene was able to activate mTOR of phosphatase and tensin homology deleted on chromosome 10 (PTEN)/tuberous sclerosis complex 1 (TSC1)/tuberous sclerosis complex 2 (TSC2) in germ cells leading to primordial follicle recruitment, POI and infertility (81)."
reach
"Akt activates mTOR through (i) phosphorylation and inhibition of tuberous sclerosis complex 2 (TSC2), which inactivates the mTOR activating GTP binding protein Rheb, and/or (ii) phosphorylation of PRAS40 a member of mTORC1, one of the two functional complexes of mTOR, which includes mLST8 and Gbl and the scaffold protein Raptor."
reach
"First, in the nucleus, p53 has been reported to promote autophagy by transactivating genes encoding : DRAM1, which is induced by DNA damage and localized to lysosomes with autophagosome accumulation; and sestrin 1 and 2, AMPK beta1 and beta2, and TSC2, which act on the AMPK pathway to inhibit the autophagy suppressor mTOR, thus activating autophagy [XREF_BIBR, XREF_BIBR]."
reach
"In this study, we provided first evidence that MALAT1 epigenetically repress TSC2 transcription via recruiting EZH2 to TSC2 promoter regions to induce H3K27me3, and thereby induce mTOR activation and subsequent autophagy inhibition.Autophagy can be activated as a stress response shortly after AMI; however, sustained ischemia impaired cardiomyocyte autophagy flux, which exacerbated the post-infarct adverse cardiac modeling [27]."
reach
"Surprisingly, F-box proteins beta-TrCP and Fbw5 were reported as substrate receptors for CRL4 beta-TrCP [XREF_BIBR] and CRL4 Fbw5 [XREF_BIBR] targeting inhibitors of mTOR signalling REDD1 (regulated in development and DNA damage response 1) and TSC2 (tuberous sclerosis protein 2) respectively."
reach
"XREF_BIBR Both sestrins can trigger the AMPK and target it to phosphorylate and activate TSC1 and TSC2 complex, thereby inhibiting the signaling of mTOR, a critical autophagy inhibitor of cells, XREF_BIBR, XREF_BIBR and so CX-5461-induced autophagy through AMPK and mTOR signaling pathway in U2-OS cells might arise from the upregulation of Sesn1/2 by p53."
reach
"Among many AMPK-substrates, phosphorylation of RPTOR (regulatory associated protein of MTOR, complex 1) and TSC2 (TSC complex subunit 2) inhibit MTOR signaling and regulate many processes including macroautophagy/autophagy.Posttranslational modification of proteins with ubiquitin orchestrates a vast number of biological processes, including targeted protein degradation by the ubiquitin-proteasome system (UPS), lysosomal/vacuolar protein degradation, endocytosis, intracellular trafficking, regulation of the secretory pathway and transcriptional regulation [3]."
reach
"We previously identified a novel interaction between tuberous sclerosis-2 (TSC2) and death associated protein kinase-1 (DAPK), the consequence being that DAPK catalyses the inactivating phosphorylation of TSC2 to stimulate mammalian target of rapamycin complex 1 (mTORC1) activity."
reach
"The canonical pathway for mTOR regulation is independent of erk1/2 and involves PI3K-PDK1-Akt-dependent inactivation of the mTOR suppressor TSC2, which then leads to mTOR-p70S6K dependent translation of mRNAs and de novo protein synthesis at active synapses (Hoeffer and Klann, 2010)."
reach
"In the presence of growth factors such as insulin or insulin like growth factors, stimulated Akt and extracellular signal regulated protein kinases 1 and 2 (ERK1/2) can phosphorylate and disrupt the tuberous sclerosis complex 1/2 (TSC1 and TSC2), which activates mTOR inhibition and thus inhibiting autophagy [XREF_BIBR]."
reach
"Because mTOR can be alternatively downregulated by tuberous sclerosis complex 2 (TSC2) activation mediated by 5 ' adenosine monophosphate activated protein kinase (AMPK), we proposed that the activation of AMPK alpha1/2 by LKB1 and/or by calmodulin dependent protein kinase kinase (CaMKK) would also block the nuclear export of PTEN in a manner similar to that of inhibitors of PI3K, mTOR, and S6K."
reach
"Recent studies also indicate that REDD1 (RTP801), induced under hypoxic conditions in a HIF-1alpha dependent manner XREF_BIBR, plays a role in the TSC1 (hamartin)/TSC2 (tuberin)-mediated inhibition of mTOR XREF_BIBR, these indicating a reciprocal regulatory control between HIF-1alpha and mTOR."
reach
"Recent studies have revealed that TSC2 plays an important role in the cell growth and proliferation pathway, in which TSC2 forms a functional complex with TSC1 and negatively regulates both growth factor and nutrient dependent activation of mTOR signalling to its downstream targets S6 kinase and 4EBP1 (Gao et al, 2002; Manning and Cantley, 2003; Saucedo et al, 2003; Stocker et al, 2003; Hay and Sonenberg, 2004)."
reach
"The down-regulation of PRAS40, Rictor, Raptor, and GbetaL, which further led to loss of mTOR complex (mTORC) 1/2 formation, activation of mTOR repressor TSC2 by suppressing Akt and activating AMPK, suppression of Cap dependent translation, and hypophosphorylation of 4EBP1 as well as induction of autophagic programmed cell death, was reported after fisetin treatment (Suh etal.,2010)."
reach
"ERK dependent phosphorylation on serine 664 of TSC2 leads to TSC1-TSC2 dissociation and impairment of TSC2 ability to inhibit mTOR signaling, suggesting that the Ras and MAPK pathway upstream of the TSC complex and that ERK may modulate mTOR signaling pathway and contribute to disease progression through phosphorylation and inactivation of TSC2 [XREF_BIBR]."
reach
"In line with cell size regulation and autophagy interplay induced by mechanical stress, we observed defaults in the mTORC1 pathway activation in FLCN knockdown cells, since phosphorylation of TSC2, known to inactivate the mTOR signaling sequence, was strongly diminished in siFLCN cells prone to shear stress (Supplemental Figure S4A and S4B)."
sparser
"Tuberous sclerosis complex (TSC) is a genetic disorder affecting approximately 1 million patients worldwide. xref TSC is caused by inactivating mutations in TSC1 or TSC2 . xref , xref The proteins encoded by TSC1 and TSC2 inhibit the translation regulatory protein mTOR. xref , xref , xref , xref TSC patients have numerous types of growths called hamartomas and malformations including in the brain. xref Neurological manifestations in TSC are the greatest cause of morbidity in patients and includes seizures, intellectual disability, and a range of TSC associated neuropsychiatric disorders (TANDs) such as behavioral, psychiatric, neuropsychological, and autistic symptoms. xref , xref , xref , xref Malformations within the cerebral cortex called cortical tubers resemble focal cortical dysplasia (II) and are epileptogenic foci that are a leading cause of patient seizures. xref , xref , xref , xref , xref , xref , xref As one would expect, surgical resection of epileptogenic tubers reduces seizure burden. xref , xref , xref Tubers can be detected during late gestation and are therefore thought to be a byproduct of abnormal development."
reach
"In response to elevated ROS (both exogenous ROS such as H O or doxorubicin and endogenous ROS such as menadione or phenylethylisothiocyanate), cytoplasmic ATM acts as an ROS sensor and activates the tuberous sclerosis 2 (TSC2) tumor suppressor via the Liver kinase B1 (LKB1) / Adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) signaling pathway to repress mammalian target of rapamycin complex 1 (mTORC1) and induce autophagy."
eidos
"Cell stress and Akt-mTORC1 / - mTORC2 signaling The serine / threonine kinase mTOR is a well-characterized substrate of Akt and it is known that Akt-mediated activation of mTOR occurs through phosphorylation and inactivation of tuberous sclerosis complex 2 ( TSC2 ) , which normally inhibits mTOR ( Hay 2005 ) ."
sparser
"Muscle hypertrophy is also influenced by the availability of nutrients and the presence of endocrine and autocrine hormones such as IGF-I. A concerted anabolic signal is generated by leucine which facilitates the translocation of the kinase mTOR to the surface of the lysosome, where it is activated by Rheb, and by IGF-I which relieves the inherent inhibition of mTOR by TSC2."
reach
"Loss of function in tuberous sclerosis complex 1 (TSC1) or 2 (TSC2) in systemic PEComas cause an activation of the mTOR pathway; however, primary cutaneous malignant PEComas are unrelated to tuberous sclerosis complex and show overactivation of the mTOR pathway by a different mechanism."